HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.

Abstract
5-Fluorouracil (5-FU) is widely used for treatment of advanced colorectal cancer. However, it is common for such patients to develop resistance to 5-FU, and this drug resistance becomes a critical problem for chemotherapy. The mechanisms underlying this resistance are largely unknown. To screen for proteins possibly responsible for 5-FU resistance, cells resistant to 5-FU were derived from human colon cancer cell lines and two-dimensional gel electrophoresis-based comparative proteomics was done. Two-dimensional gel electrophoresis data showed there was lower expression of the alpha subunit of mitochondrial F(1)F(0)-ATP synthase (ATP synthase) in 5-FU-resistant cells compared with parent cells. Western blotting showed that expression of other ATP synthase complex subunits was also lower in 5-FU-resistant cell lines and that these resistant cells also showed decreased ATP synthase activity and reduced intracellular ATP content. The ATP synthase inhibitor, oligomycin A, strongly antagonized 5-FU-induced suppression of cell proliferation. When 5-FU sensitivity was compared with ATP synthase activity in six different human colon cancer cell lines, a positive correlation has been found. Furthermore, suppressed ATP synthase d-subunit expression by siRNA transfection increased cell viability in the presence of 5-FU. Bioenergetic dysfunction of mitochondria has been reported as a hallmark of many types of cancers (i.e., down-regulation of ATP synthase beta-subunit expression in liver, kidney, colon, squamous oesophageal, and lung carcinomas, as well as in breast and gastric adenocarcinomas). Our findings show that ATP synthase down-regulation may not only be a bioenergetic signature of colorectal carcinomas but may also lead to cellular events responsible for 5-FU resistance.
AuthorsYoung-Kyoung Shin, Byong Chul Yoo, Hee Jin Chang, Eunkyung Jeon, Sung-Hye Hong, Mi-Sun Jung, Soo-Jeong Lim, Jae-Gahb Park
JournalCancer research (Cancer Res) Vol. 65 Issue 8 Pg. 3162-70 (Apr 15 2005) ISSN: 0008-5472 [Print] United States
PMID15833846 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimetabolites, Antineoplastic
  • Aurovertins
  • Enzyme Inhibitors
  • Oligomycins
  • RNA, Small Interfering
  • oligomycin A
  • aurovertin B
  • F1F0-ATP synthase
  • Mitochondrial Proton-Translocating ATPases
  • Fluorouracil
Topics
  • Antimetabolites, Antineoplastic (pharmacology)
  • Aurovertins (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Colonic Neoplasms (drug therapy, enzymology, genetics)
  • Down-Regulation
  • Drug Resistance, Neoplasm
  • Energy Metabolism
  • Enzyme Inhibitors (pharmacology)
  • Fluorouracil (pharmacology)
  • Humans
  • Mitochondria (enzymology)
  • Mitochondrial Proton-Translocating ATPases (antagonists & inhibitors, biosynthesis, genetics)
  • Oligomycins (pharmacology)
  • RNA, Small Interfering (genetics)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: